Toprak Omer, Cirit Mustafa, Yesil Murat, Bayata Serdar, Tanrisev Mehmet, Varol Umut, Ersoy Rifki, Esi Ertap
Department of Nephrology, Ataturk Training and Research Hospital, 35360 Izmir, Turkey.
Nephrol Dial Transplant. 2007 Mar;22(3):819-26. doi: 10.1093/ndt/gfl636. Epub 2006 Nov 7.
The aim of the present study was to assess the influence of diabetic and pre-diabetic state on the development of contrast-induced nephropathy (CIN) in chronic kidney disease patients undergoing coronary angiography.
A total of 421 patients with Cockcroft clearance between 15 and 60 ml/min were divided into three groups [diabetes mellitus (DM), n = 137; pre-diabetes (pre-DM), n = 140; and normal fasting glucose (NFG), n = 144]. CIN was defined as an increase of > or =25% in creatinine over baseline within 48 h of angiography, DM as glucose > or =126 mg/dl, pre-DM as glucose between 100 and 125 mg/dl and NFG as glucose <100 mg/dl.
CIN occurred in 20% of the DM [relative risk (RR) 3.6, P = 0.001], 11.4% of the pre-DM (RR 2.1, P = 0.314) and 5.5% of the NFG group. The decrease of glomerular filtration rate (GFR) was higher in DM and pre-DM (P = 0.001 and P = 0.002, respectively). GFR < or =30 ml/min (RR 19.22), multivessel involvement (RR 7.59), hyperuricaemia (RR 3.95), use of angiotensin-converting enzyme inhibitors or angiotensin II receptor blocker (RR 2.70) and DM (RR 2.34) were predictors of CIN. Length of hospital stay was 2.45 +/- 1.45 day in DM, 2.27 +/- 0.68 day in pre-DM and 1.97 +/- 0.45 day in NFG (P < 0.001, DM vs NFG and P = 0.032, pre-DM vs NFG). The rate of major adverse cardiac events was 8.7% in DM, 5% in pre-DM and 2.1% in NFG (P = 0.042, DM vs NFG). Haemodialysis was required in 3.6% of DM and 0.7% in pre-DM (P = 0.036, DM vs NFG), and the total number of haemodialysis sessions during 3 months was higher in DM and pre-DM (P < 0.001). Serum glucose > or =124 mg/dl was the best cut-off point for prediction of CIN.
Our data support that patients with DM are at a higher risk of developing CIN, but patients with pre-DM are not at as high a risk for developing CIN as diabetes patients.
本研究旨在评估糖尿病状态和糖尿病前期状态对接受冠状动脉造影的慢性肾脏病患者发生对比剂肾病(CIN)的影响。
将421例肌酐清除率在15至60 ml/分钟之间的患者分为三组[糖尿病(DM)组,n = 137;糖尿病前期(pre-DM)组,n = 140;空腹血糖正常(NFG)组,n = 144]。CIN定义为血管造影后48小时内肌酐较基线水平升高≥25%,DM定义为血糖≥126 mg/dl,pre-DM定义为血糖在100至125 mg/dl之间,NFG定义为血糖<100 mg/dl。
CIN发生率在DM组为20%[相对危险度(RR)3.6,P = 0.001],pre-DM组为11.4%(RR 2.1,P = 0.314),NFG组为5.5%。DM组和pre-DM组肾小球滤过率(GFR)下降更明显(分别为P = 0.001和P = 0.002)。GFR≤30 ml/分钟(RR 19.22)、多支血管受累(RR 7.59)、高尿酸血症(RR 3.95)、使用血管紧张素转换酶抑制剂或血管紧张素II受体阻滞剂(RR 2.70)以及DM(RR 2.34)是CIN的预测因素。DM组住院时间为2.45±1.45天,pre-DM组为2.27±0.68天,NFG组为1.97±0.45天(P<0.001,DM组与NFG组比较;P = 0.032,pre-DM组与NFG组比较)。主要不良心脏事件发生率在DM组为8.7%,pre-DM组为5%,NFG组为2.1%(P = 0.042,DM组与NFG组比较)。DM组3.6%的患者需要血液透析,pre-DM组为0.7%(P = 0.036,DM组与NFG组比较),且DM组和pre-DM组在3个月内血液透析总次数更多(P<0.001)。血清葡萄糖≥124 mg/dl是预测CIN的最佳切点。
我们的数据支持DM患者发生CIN的风险更高,但pre-DM患者发生CIN的风险不如糖尿病患者高。